Evogene director discloses stock option holdings
Evogene Ltd. director Sarit Firon filed an initial Form 3 disclosing stock option holdings in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Evogene Ltd. director Sarit Firon filed an initial Form 3 disclosing stock option holdings in the company. The filing lists multiple stock option grants over ordinary shares with exercise prices ranging from 1.2900 to 70.5500 per share and expiration dates between 2026 and 2035. One grant for options over 2,500 ordinary shares at an exercise price of 1.2900 vests in equal quarterly installments of 25%, becoming fully vested on the one-year anniversary of the August 18, 2025 grant date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| Holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
Footnotes (1)
- F1. The options reported in this row vest equally on a quarterly basis (25% per quarter) such that they will be fully vested on the one-year anniversary of the August 18, 2025 grant date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Evogene (EVGN) disclose in Sarit Firon’s Form 3 filing?
What stock option grants are reported for Evogene (EVGN) director Sarit Firon?
How do the lowest-priced Evogene (EVGN) options held by Sarit Firon vest?
Does Sarit Firon’s Evogene (EVGN) Form 3 show any stock purchases or sales?
What is the time span of Evogene (EVGN) option expirations reported for Sarit Firon?
AI-generated analysis. How Rhea-AI works. Not financial advice.
